Latest Articles

Publication Date
[Efficacy and safety of triptorelin acetate microspheres for injection versus triptorelin acetate for injection in Chinese patients with endometriosis: a multicenter, randomized, double-blind, phase Ⅲ non-inferiority clinical trial].

Objective: To evaluate the efficacy and safety of triptorelin acetate microspheres for injection compared with triptorelin acetate for injection in the treatment of endometriosis. Methods: A total of 392 patients …

Published: Jan. 31, 2026, midnight
Epigenetic Mechanisms of Reproductive Dysfunction Induced by Endocrine-Disrupting Chemicals: Evidence From Molecular Studies.

Endocrine-disrupting chemicals (EDCs), including bisphenol A (BPA), phthalates, organochlorine pesticides, and heavy metal ions, pose serious threats to reproductive health by interfering with hormonal balance and molecular signaling pathways. Recent …

Published: Jan. 30, 2026, midnight
Attenuated Cyclooxygenase-Mediated Vasodilation in Cutaneous Microvasculature with No Difference in Platelet Aggregation in Women with Endometriosis.

Endometriosis is a systemic inflammatory disease known to increase the risk of cardiovascular disease. The inducible form of cyclooxygenase (COX), COX-2, is an inflammatory enzyme upregulated in endometriosis with COX …

Published: Jan. 30, 2026, midnight
Safety evaluation of percutaneous intrauterine hydrodissection in microwave ablation of uterine fibroids adjacent to the endometrium.

To assess the safety and efficacy of percutaneous intrauterine hydrodissection as a protective technique during microwave ablation (MWA) of uterine fibroids adjacent to the endometrium.

Published: Jan. 30, 2026, midnight
Brionna Kirkendoll Faced Stage IV Endometriosis After Years of Birth Control Masked Her Symptoms - Endometriosis Foundation of America

Brionna Kirkendoll Faced Stage IV Endometriosis After Years of Birth Control Masked Her Symptoms Endometriosis Foundation of America

Published: Jan. 29, 2026, 6:53 p.m.
Aprea Therapeutics Announces Early Clinical Proof-Of-Concept in the Ongoing ACESOT-1051 Dose-Escalation Trial Evaluating WEE1 Inhibitor APR-1051, Including Partial Response Observed on First Scan - The Manila Times

Aprea Therapeutics Announces Early Clinical Proof-Of-Concept in the Ongoing ACESOT-1051 Dose-Escalation Trial Evaluating WEE1 Inhibitor APR-1051, Including Partial Response Observed on First Scan The Manila Times

Published: Jan. 29, 2026, 1:43 p.m.
“Faceless Women”: Mabi Sanna’s art on display at Palazzo Tirso - unicaradio.it

“Faceless Women”: Mabi Sanna’s art on display at Palazzo Tirso unicaradio.it

Published: Jan. 29, 2026, 11:52 a.m.
Endometriosis “the missed disease” in the workplace - The HR Director

Endometriosis “the missed disease” in the workplace The HR Director

Published: Jan. 29, 2026, 10:01 a.m.
The effect of tinzaparin sodium and leuprolide acetate in an experimental mouse model of endometriosis: The rol of the WNT/beta-catenin pathway.

Endometriosis is a benign condition driven by estrogen and inflammation in which endometrial-like tissue develops in ectopic locations. We aimed to determine whether non-steroidal agents acting on the WNT/beta-catenin signaling …

Published: Jan. 29, 2026, midnight
Baldwin Family Member Could Face Jail Time After Recent Arrest - suggest.com

Baldwin Family Member Could Face Jail Time After Recent Arrest suggest.com

Published: Jan. 28, 2026, 12:08 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!